comprehensive -WSS

comprehensive

author：explore 2025-08-12 08:30:03 - browse：977

Under the Affordable Care Act, health insurers are required to cover all costs associated with preventive care — including PrEP, or pre-exposure prophylactic treatment for HIV. But now all preventive care coverage is under threat, thanks to a lawsuit filed by employers who believe they shouldn’t be required to pay for care that violates their religious beliefs.

While coverage for PrEP access is largely unchanged as the court case makes its way through the legal system, Richard Hughes IV, a partner with the law firm Epstein Becker Green, says that protecting the status quo isn’t enough. For instance, currently you have to jump through extra hoops to get long-acting injectable PrEP covered by insurance.

But Hughes has a better idea for how to not only protect but also expand access to PrEP.

On this episode of the “First Opinion Podcast,” I spoke to Hughes about his proposal, why access to PrEP has never been what it should be, the Supreme Court’s current approach to health care, and more.

“If a provider has a bad experience with a previous patient experiencing non-coverage, they might say to the next patient, ‘Well, I’m not sure this is going to be covered.’ And that can be really discouraging,” Hughes said. “What we really need to create that clarity for patients is for this law to be upheld, for the recommendations to be clear, and for providers to have the assurance that they will be covered by payers.”

Our conversation was based on his recent First Opinion op-ed, “How to protect PrEP coverage, no matter what happens in Braidwood v. Becerra.”

Be sure to sign up for the weekly “First Opinion Podcast” on Apple Podcasts, Stitcher, Google Play, or wherever you get your podcasts.

And if you have any feedback for us — First Opinion authors to feature on the podcast, kudos, or darts — email us at [email protected] and please put “podcast” in the subject line.

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： ‘The Bear’ and hospitality in hospitals

WSS

In venture capital firm's success, lessons for turning crisis into profit

Zapping the brain for stroke rehab: Pivotal clinical trial begins

WHO may add ‘noma' to its list of neglected tropical diseases

Testing for cancer recurrence creates a new limbo for patients

Judge rejects Trump's counterclaim against E. Jean Carroll

Mega Millions jackpot estimated at record $1.58 billion for Tuesday's drawing

focus

comprehensive

Wikipedia

Heart attack and stroke risk calculators need revising

Paying for Covid pills will soon shift to insurers

Moonlake's readout produced a cash windfall. Risks remain

Eli Lilly to pay $200M for Beam’s stake in gene

The cancer drug shortage isn’t new — and neither are the solutions

Emergency medicine has repudiated 'excited delirium.' Now what?

The cancer drug shortage isn’t new — and neither are the solutions

Eli Lilly to pay $200M for Beam’s stake in gene

Medical records are filled with copy

More regulation could be coming for drug ads

hotspot

More regulation could be coming for drug ads

Hospitals use virtual reality to design more inclusive rooms for kids

Readout Newsletter: XBI biotech index, Akero Therapeutics

The painfully weak evidence on taking collagen to treat arthritis

Paying for Covid pills will soon shift to insurers

Travel bans should be based on evidence, not politics or fear

Wikipedia

focus

leisure time

hotspot